News and Events
When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.
Fewer than three out of five women with cervical cancer received guideline-based care, a new study finds. For black and Hispanic women, it’s just over half, which could help explain why cervical cancer outcomes tend to be worse for these women.
A new study from researchers at the University of Michigan Comprehensive Cancer Center identifies a protein in that microenvironment that promotes the spread of breast cancer cells. It’s part of a well-known family of receptors for which promising inhibitors are being developed.